Currently holds a position at Lexicon Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
President, Chief Executive Officer, Director | Lexicon Pharmaceuticals Inc | July 7, 2014 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-06-29 | 2023-06-29 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
B Purchase |
10,000
+1.2%
2.1621,600 USD |
10,000 +1.2% | 2.16 | 21,600 USD | |
2023-06-26 | 2023-06-23 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
B Purchase |
10,000
+1.3%
2.5024,950 USD |
10,000 +1.3% | 2.50 | 24,950 USD | |
2019-09-19 | 2019-09-18 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
B Purchase |
50,000
+28.2%
3.10155,000 USD |
50,000 +28.2% | 3.10 | 155,000 USD | |
2019-09-18 | 2019-09-17 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
B Purchase |
40,290
+29.4%
3.13126,108 USD |
40,290 +29.4% | 3.13 | 126,108 USD | |
2019-09-18 | 2019-09-17 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
B Purchase |
277
+0.2%
3.13867 USD |
277 +0.2% | 3.13 | 867 USD | |
2019-09-18 | 2019-09-17 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
B Purchase |
6,333
+4.8%
3.1219,759 USD |
6,333 +4.8% | 3.12 | 19,759 USD | |
2019-09-18 | 2019-09-17 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
B Purchase |
3,000
+2.4%
3.129,357 USD |
3,000 +2.4% | 3.12 | 9,357 USD | |
2019-09-18 | 2019-09-17 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
B Purchase |
100
+0.1%
3.13313 USD |
100 +0.1% | 3.13 | 313 USD |